ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

N4P N4 Pharma Plc

0.80
-0.025 (-3.03%)
Última actualización: 04:33:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
N4 Pharma Plc N4P London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.025 -3.03% 0.80 04:33:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.825 0.80 0.825 0.825
más cotizaciones de acciones »
Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202401:00UK RNSN4 Pharma PLC N4 Pharma Webinar on SRI Collaboration
25/4/202405:56ALNCNewsN4 Pharma strikes partnership deal for intracellular..
25/4/202401:38UK RNSN4 Pharma PLC Collaboration Agreement with SRI International..
23/4/202407:32ALNCNewsIN BRIEF: N4 Pharma loss widens but "great optimism" remains
23/4/202401:00UK RNSN4 Pharma PLC Final Results
18/4/202406:14ALNCNewsN4 Pharma sees potential in Nuvec delivery method for cancer..
18/4/202401:00UK RNSN4 Pharma PLC Oral Delivery Update
04/3/202409:13UK RNSN4 Pharma PLC Holding(s) in Company
29/2/202401:00UK RNSN4 Pharma PLC Holding(s) in Company
15/2/202406:06ALNCNewsIN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec..
15/2/202401:00UK RNSN4 Pharma PLC in-vitro siRNA update
19/1/202403:26ALNCNewsIN BRIEF: N4 Pharma gets India patent for medical delivery..
19/1/202401:00UKREGN4 Pharma PLC Patent Grant
18/1/202404:15UKREGN4 Pharma PLC Holding(s) in Company
16/1/202407:26ALNCNewsIN BRIEF: N4 Pharma touts contract to test glaucoma..
16/1/202401:00UKREGN4 Pharma PLC Nanogenics Update
08/1/202410:24UKREGN4 Pharma PLC Holding(s) in Company
08/1/202403:11ALNCNewsN4 Pharma hails increased efficacy of Nuvec when complexed..
08/1/202401:00UKREGN4 Pharma PLC AAV Viral Vector Update
18/12/202306:43ALNCNewsN4 Pharma rises on successful results from Nuvec..
18/12/202301:00UKREGN4 Pharma PLC Oral Delivery Update
07/12/202312:28ALNCNewsTRADING UPDATES: N4 Pharma hails "encouraging" siRNA..
07/12/202305:28UKREGN4 Pharma PLC Holding(s) in Company
07/12/202301:00UKREGN4 Pharma PLC Nuvec(R) R&D and Strategy Update
01/12/202308:29ALNCNewsTRADING UPDATES: N4 launches investor hub; Capricorn..
30/11/202303:00RNSNONN4 Pharma PLC N4 Pharma Launches New Interactive Investor..
31/10/202302:00UKREGN4 Pharma PLC Total Voting Rights
09/10/202301:00RNSNONN4 Pharma PLC Investor Presentation via Investor Meet..
03/10/202302:15UKREGN4 Pharma PLC Holding(s) in Company
02/10/202301:00RNSNONN4 Pharma PLC Investor Presentation
28/9/202304:20ALNCNewsN4 Pharma shares fall as places shares to fund Nanogenics..
28/9/202301:00UKREGN4 Pharma PLC Acquisition of Controlling Interest in..
12/9/202307:43ALNCNewsN4 Pharma interim loss narrows slightly as business outreach..
12/9/202301:00UKREGN4 Pharma PLC Interim Results
25/7/202304:12ALNCNewsN4 Pharma shares soar on further patent grant for Nuvec in..
25/7/202301:00UKREGN4 Pharma PLC Patent Grant and Board Change
27/6/202306:13ALNCNewsIN BRIEF: N4 Pharma expands Professor Yu partnership on..
27/6/202301:00RNSNONN4 Pharma PLC Grant Award for Professor Chengzhong Yu

Su Consulta Reciente

Delayed Upgrade Clock